Does Fatty Liver Cause Farting and Bloating?

Fatty liver disease is a common condition in the UK, and many people wonder whether it can cause excessive wind and bloating. While fatty liver does not directly produce gas, it can indirectly contribute to digestive symptoms through changes in bile production, gut bacteria and the gut-liver axis. Understanding the connection between liver health and digestive discomfort can help you recognise when symptoms may warrant a GP visit and what steps can be taken to manage both your liver and gut health effectively.

Can a fatty liver cause excessive wind and bloating?

Fatty liver disease can indirectly cause wind and bloating through gut dysbiosis and metabolic changes, though it does not directly produce gas and is rarely the sole cause of these symptoms.

Fatty liver disease may contribute to excessive wind and bloating, though it does so indirectly rather than by directly producing gas itself. The liver plays a central role in digestion, bile production and gut motility, and when these processes are disrupted, increased gas production and abdominal discomfort can result. It is important to note that in early metabolic dysfunction-associated steatotic liver disease (MASLD), liver synthetic function is often preserved and liver function tests may be normal; the digestive effects described below tend to arise from metabolic and gut-environment changes rather than frank liver failure.

Non-alcoholic fatty liver disease (NAFLD), now more commonly referred to as MASLD, is one of the most common liver conditions in the UK.^[1][13] It is closely linked to obesity, type 2 diabetes and metabolic syndrome, all of which are independently associated with gut symptoms including bloating, flatulence and altered bowel habits.

Research suggests that people with fatty liver disease may have changes in their gut microbiome, a condition known as gut dysbiosis. An imbalance in gut bacteria can lead to increased fermentation of undigested food, producing excess gas. Additionally, fatty liver disease has been observed to co-occur with conditions such as irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO), both of which are recognised causes of bloating and flatulence, though the strength of these associations varies and the evidence continues to develop.^[10][11]

It is important to note that wind and bloating are very common symptoms with many possible causes, including diet, food intolerances and other gastrointestinal conditions. Fatty liver disease is unlikely to be the sole explanation for these symptoms, and a thorough clinical assessment is needed to identify the underlying cause. If you are experiencing persistent or troublesome digestive symptoms, speaking to your GP is the appropriate first step.

Why does liver disease affect your digestive system?

The liver produces bile essential for fat digestion and regulates the gut environment via the gut-liver axis; disruption in fatty liver disease can alter gut bacteria, intestinal permeability and motility, causing bloating and flatulence.

Liver disease affects the digestive system because the liver is directly involved in producing bile, processing nutrients and regulating the gut environment. Bile, produced by the liver and stored in the gallbladder, is essential for the digestion and absorption of dietary fats.^[9] In more advanced liver disease, bile production and flow can be altered, leading to incomplete fat digestion, which in turn can cause bloating, loose stools and increased gas. In uncomplicated early MASLD, significant bile flow impairment is less typical, though metabolic changes may still affect digestive comfort.

The liver also processes toxins and metabolic by-products absorbed from the gut via the portal vein, a pathway known as the gut-liver axis. Disruption to this axis in fatty liver disease may alter the composition of gut bacteria, promote increased intestinal permeability and trigger low-grade inflammation throughout the digestive tract. These changes can slow gut motility, leading to constipation, or speed it up, causing diarrhoea, both of which are associated with increased flatulence.

In more advanced liver disease, such as cirrhosis, portal hypertension can develop. This raises pressure in the blood vessels supplying the gut, which may cause fluid accumulation in the abdomen (ascites) and contribute to significant bloating. At this stage, symptoms are considerably more pronounced and require specialist management.

Even in early-stage fatty liver disease, the metabolic environment created by insulin resistance and excess liver fat can influence gut hormone secretion and appetite regulation, further disrupting normal digestive function. Understanding this gut-liver connection helps explain why digestive symptoms are commonly reported by people with fatty liver disease, even when the liver condition itself is relatively mild.

What other symptoms usually appear alongside a fatty liver?

Fatty liver disease is often silent, but common symptoms include fatigue, upper right abdominal discomfort and bloating; advanced disease may cause jaundice, ascites and easy bruising.

Fatty liver disease is often described as a "silent" condition because many people have no symptoms at all in its early stages, with the condition discovered incidentally during blood tests or an ultrasound scan. However, some people do experience a range of symptoms that may prompt them to seek medical advice.

Common symptoms associated with fatty liver disease include:

• Fatigue and low energy, which can be persistent and disproportionate to activity levels

• A dull ache or discomfort in the upper right abdomen, where the liver is located

• Bloating, wind and nausea, particularly after fatty meals

Because MASLD is closely associated with metabolic syndrome, many people also have related conditions such as high blood pressure, raised cholesterol, type 2 diabetes or prediabetes. Central adiposity (excess weight around the abdomen) is a recognised risk factor for MASLD rather than a direct symptom of it, and these associated conditions may themselves cause symptoms or be identified during the same clinical workup.

Some people report difficulty concentrating alongside fatigue, though this is a non-specific symptom with many possible causes and is not a recognised feature of early MASLD in the way that hepatic encephalopathy is a feature of advanced liver disease.

In more advanced liver disease, where significant scarring (fibrosis or cirrhosis) has developed, additional symptoms may appear, including:

• Jaundice (yellowing of the skin or whites of the eyes)

• Swollen ankles or legs due to fluid retention

• Abdominal swelling from ascites

• Easy bruising or bleeding, reflecting impaired clotting factor production

These more serious symptoms indicate significant liver damage and require prompt medical assessment. It is worth noting that many of the milder symptoms, such as fatigue and bloating, are non-specific and can have numerous other causes, so clinical investigation is essential before attributing them to fatty liver disease.

When should you see a GP about bloating and digestive problems?

See your GP if bloating or digestive symptoms persist for more than three weeks, are worsening, or are accompanied by unexplained weight loss, blood in stools or jaundice.

You should see your GP about bloating and digestive problems if symptoms are persistent, worsening or accompanied by other concerning features that suggest an underlying medical condition. Occasional wind and bloating are extremely common and are usually related to diet, eating habits or minor gut disturbances. However, certain patterns of symptoms warrant professional evaluation.

Contact your GP if you experience any of the following:

• Bloating or abdominal discomfort that has lasted more than three weeks without a clear dietary explanation (NHS guidance advises seeing a GP if bloating is present most days for three weeks or more)^[4]

• Unexplained weight loss alongside digestive symptoms

• Blood in your stools or black, tarry stools

• Persistent nausea or vomiting

• Yellowing of the skin or eyes (jaundice)

• Significant fatigue that is affecting your daily life

• A noticeable lump or swelling in the abdomen

• Symptoms that wake you from sleep, which can indicate an organic rather than functional cause

If you have known risk factors for fatty liver disease, such as obesity, type 2 diabetes, high cholesterol or a history of heavy alcohol use, it is particularly worth discussing digestive symptoms with your GP, as these may prompt investigation of liver health alongside other causes.

For urgent symptoms such as sudden severe abdominal pain, vomiting blood or signs of serious illness, call 999 or go to your nearest accident and emergency department immediately. For symptoms that are concerning but not immediately life-threatening, NHS 111 can provide guidance on the appropriate level of care.

Your GP can arrange relevant blood tests, imaging and referrals to gastroenterology or hepatology if needed, ensuring that both digestive and liver health are properly assessed.

How is fatty liver diagnosed and managed on the NHS?

Fatty liver is diagnosed using liver function tests, abdominal ultrasound and fibrosis scoring tools such as ELF or FIB-4; management centres on lifestyle modification including weight loss, a balanced diet and regular physical activity.

Fatty liver disease is diagnosed on the NHS through a combination of blood tests, imaging and, in some cases, liver biopsy or non-invasive fibrosis assessment. Initial investigation typically involves liver function tests (LFTs), a fasting lipid profile, blood glucose or HbA1c, and a full blood count. An abdominal ultrasound scan is the most commonly used imaging tool and can detect increased fat in the liver, though it cannot reliably quantify the degree of fibrosis.

NICE guidance on non-alcoholic fatty liver disease (NG49) recommends that people with suspected NAFLD or MASLD are assessed for the degree of liver fibrosis using validated non-invasive tools such as the Enhanced Liver Fibrosis (ELF) test or FIB-4 score, which help stratify risk and guide onward referral.^[2][12] Those with significant fibrosis may be referred to a hepatologist for further assessment, which could include a FibroScan (transient elastography) or liver biopsy. Some UK guidance continues to use the term NAFLD alongside MASLD; both refer to the same condition.

Management of fatty liver disease on the NHS is primarily focused on lifestyle modification. At the time of writing, there is no pharmacological treatment specifically licensed for MASLD in the UK, though the licensing landscape is evolving and readers should check current MHRA and NICE guidance for the latest position.^[2][8] NICE-recommended approaches include:

• Sustained weight loss of 7 to 10% of body weight, which evidence suggests can reduce liver fat and inflammation (per NICE NG49 and EASL guidelines)^[2]

• A balanced, reduced-calorie diet with limited saturated fat, refined carbohydrates and added sugars

• Regular physical activity, in line with UK Chief Medical Officers' guidance recommending at least 150 minutes of moderate-intensity activity per week for adults^[5][6]

• Alcohol reduction or abstinence, particularly in alcohol-related fatty liver disease

• Management of associated conditions such as type 2 diabetes, hypertension and dyslipidaemia

For people with obesity and fatty liver disease, weight management support may be available through NHS specialist services. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options may be considered. Referral pathways and local commissioning decisions are made by Integrated Care Boards (ICBs), so availability of specific services may vary by region. Suspected adverse effects from any prescribed medicine can be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Scientific References

1. Non-alcoholic fatty liver disease (NAFLD).
2. Metabolic dysfunction-associated steatotic liver disease (NAFLD): assessment and management. Guideline NG49.
3. MRI-based technologies for assessing non-alcoholic fatty liver disease: diagnostic tests guidance.
4. Bloating.
5. Physical activity guidelines: UK Chief Medical Officers' report.
6. UK Chief Medical Officers' physical activity guidelines (full guidance page).
7. Physical activity guidelines for adults aged 19 to 64.
8. Resmetirom (Rezdiffra) authorised to treat metabolic dysfunction-associated steatohepatitis (MASH) in adults.
9. Fat digestion and absorption: Normal physiology.
10. Incidence and Characterization of SIBO in NAFLD Patients. Euroasian Journal of Hepato-Gastroenterology.
11. Small intestinal bacterial overgrowth in gastrointestinal diseases – a consequence or a cause of progression? Voprosy Pitaniia.
12. Metabolic dysfunction-associated steatotic liver disease (NG49): recommendations for research.
13. Rezdiffra (resmetirom): EPAR public assessment report.

Frequently Asked Questions